OBJECTIVE There is growing evidence that uridine may act as an endogenous neuromodulator with a potential signaling role in the central nervous system in addition to its function in pyrimidine metabolism.We previously...OBJECTIVE There is growing evidence that uridine may act as an endogenous neuromodulator with a potential signaling role in the central nervous system in addition to its function in pyrimidine metabolism.We previously found that acute morphine treatment significantly increased uridine release in the dorsal striatum of mice,while the mechanism involved in morphine-induced uridine release and the role of uridine in morphine-induced neurobehavioral changes have not been understood.METHODS Uridine release in the dorsal striatum of mice was assessed by in vivo microdialysis coupled with high performance liquid chromatography(HPLC) after morphine treatment.Western blotting and immunofluorescence were used to evaluate the expression of uridine-related proteins.Morphine-induced neurobehavioral changes were assessed by locomotor activity,behavioral sensitization and conditioned place preference(CPP)test.The expression of NT5E,an extracellular enzyme involved in formation of nucleosides,including uridine,was specifically knocked down in the dorsal striatum of mice using adeno-associated virus(AAV)-mediated short hairpin RNA(shRNA).RESULTS Both acute and chronic morphine administration significantly increased uridine release in the dorsal striatum,and this was associated with upregulation of NT5E but not other uridine-related proteins.Inhibition of NT5E with APCP or shRNA markedly inhibited morphine-induced uridine release in the dorsal striatum and related neurobehavioral changes,including hyperlocomotor activity,behavioral sensitization and CPP.CONCLUSION The present study increases our understanding of the contribution of NT5E in regulating morphine-induced neurobehavioral changes,at least as related to uridine,and suggests that NT5E may be a novel therapeutic target to manage morphine abuse.展开更多
Objective: To verify possible relations between 5'-nucleotidase, xanthine oxidase to E3 small ubiquitin-like modifier-protein ligase non structural maintenance of chromosomes elements 2 in sera patients with kidne...Objective: To verify possible relations between 5'-nucleotidase, xanthine oxidase to E3 small ubiquitin-like modifier-protein ligase non structural maintenance of chromosomes elements 2 in sera patients with kidney stones and to evaluate the possibility of a new biomarker for the evaluation of kidney damage. Methods: A sixty patients with known kidney stones who appeared the government health clinics in Kuantan–Pahang and fifty apparently healthy were taken as control group. The 5'-nucleotidase,xanthine oxidase and other biochemical parameters were measured by colorimetric tests. The serum NSMCE2 were measured by enzyme linked immunosorbent assay.Results: The mean serum xanthine oxidase [(39.98±19.70) IU/L] and ecto-5'-nucleotidase activity(40.03±9.53 IU/L) were significantly higher than the controls' levels of(18.04 ±6.26) and(16.06 ±4.61) IU/L respectively. There were 85.00% and 83.33%, of patients with kidney stones who had abnormal ecto-5'-nucleotidase activity and uric acid respectively while xanthine oxidase activity was less sensitive 58.33%.Conclusions: The present study suggests that the increase in serum of xanthine oxidase,ecto-5'-nucleotidase activities E3 small ubiquitin-like modifier-protein ligase NSE2 concentration can be used as biomarkers for diagnosis of kidney damage in patients with kidney stone,also in developments of change DNA damage and inflammation disorders in these patients.展开更多
针对实时行人检测场景存在遮挡、形态姿势不同的行人目标,YOLOv5模型对于这些目标检测有明显的漏检问题,提出一种像素差异度注意力机制(pixel difference attention,PDA),不同于传统的通道注意力机制用全局均值池化(global average pool...针对实时行人检测场景存在遮挡、形态姿势不同的行人目标,YOLOv5模型对于这些目标检测有明显的漏检问题,提出一种像素差异度注意力机制(pixel difference attention,PDA),不同于传统的通道注意力机制用全局均值池化(global average pooling,GAP)、全局最大值池化(global max pooling,GMP)来概括整张特征图的信息,全局池化将空间压缩成一个值来表征整个通道,造成了空间信息的流失,PDA将空间信息沿高和宽分别压缩,并将其分别与通道信息联系起来做注意力加权操作,同时提出一种新的通道描述指标表征通道信息,增强空间信息与通道信息的交互,使模型更容易关注到综合了空间和通道维度上的特征图的重要信息,在主干网络末端插入PDA后使模型平均精度(mean average precision,mAP)0.5提升了2.4个百分点,mAP0.5:0.95提升了4.4个百分点;针对实时检测场景的部署和检测速度要求模型拥有较少的参数量和计算量,因此提出了新的轻量化特征提取模块AC3代替原YOLOv5模型中的C3模块,该模块使插入PDA后的改进模型在精度仅仅损失0.2个百分点的情况下,参数量(parameters,Param.)减少了20%左右,浮点运算量(giga floating-point operations,GFLOPs)减少了30%左右。实验结果表明,最终的改进模型比YOLOv5s原模型在VOC行人数据集上mAP0.5提升了2.2个百分点,mAP0.5:0.95提升了3.1个百分点,且参数量减少了20%左右,浮点运算量减少了30%左右,在GTX1050上的检测速度(frames per second,FPS)提升了4。展开更多
基金National Natural Science Foundation of China(81373383).
文摘OBJECTIVE There is growing evidence that uridine may act as an endogenous neuromodulator with a potential signaling role in the central nervous system in addition to its function in pyrimidine metabolism.We previously found that acute morphine treatment significantly increased uridine release in the dorsal striatum of mice,while the mechanism involved in morphine-induced uridine release and the role of uridine in morphine-induced neurobehavioral changes have not been understood.METHODS Uridine release in the dorsal striatum of mice was assessed by in vivo microdialysis coupled with high performance liquid chromatography(HPLC) after morphine treatment.Western blotting and immunofluorescence were used to evaluate the expression of uridine-related proteins.Morphine-induced neurobehavioral changes were assessed by locomotor activity,behavioral sensitization and conditioned place preference(CPP)test.The expression of NT5E,an extracellular enzyme involved in formation of nucleosides,including uridine,was specifically knocked down in the dorsal striatum of mice using adeno-associated virus(AAV)-mediated short hairpin RNA(shRNA).RESULTS Both acute and chronic morphine administration significantly increased uridine release in the dorsal striatum,and this was associated with upregulation of NT5E but not other uridine-related proteins.Inhibition of NT5E with APCP or shRNA markedly inhibited morphine-induced uridine release in the dorsal striatum and related neurobehavioral changes,including hyperlocomotor activity,behavioral sensitization and CPP.CONCLUSION The present study increases our understanding of the contribution of NT5E in regulating morphine-induced neurobehavioral changes,at least as related to uridine,and suggests that NT5E may be a novel therapeutic target to manage morphine abuse.
基金Support from the International Islamic University Malaysia,the research management center Grant Scheme project no.IIUM/504/5/29/1
文摘Objective: To verify possible relations between 5'-nucleotidase, xanthine oxidase to E3 small ubiquitin-like modifier-protein ligase non structural maintenance of chromosomes elements 2 in sera patients with kidney stones and to evaluate the possibility of a new biomarker for the evaluation of kidney damage. Methods: A sixty patients with known kidney stones who appeared the government health clinics in Kuantan–Pahang and fifty apparently healthy were taken as control group. The 5'-nucleotidase,xanthine oxidase and other biochemical parameters were measured by colorimetric tests. The serum NSMCE2 were measured by enzyme linked immunosorbent assay.Results: The mean serum xanthine oxidase [(39.98±19.70) IU/L] and ecto-5'-nucleotidase activity(40.03±9.53 IU/L) were significantly higher than the controls' levels of(18.04 ±6.26) and(16.06 ±4.61) IU/L respectively. There were 85.00% and 83.33%, of patients with kidney stones who had abnormal ecto-5'-nucleotidase activity and uric acid respectively while xanthine oxidase activity was less sensitive 58.33%.Conclusions: The present study suggests that the increase in serum of xanthine oxidase,ecto-5'-nucleotidase activities E3 small ubiquitin-like modifier-protein ligase NSE2 concentration can be used as biomarkers for diagnosis of kidney damage in patients with kidney stone,also in developments of change DNA damage and inflammation disorders in these patients.
文摘针对实时行人检测场景存在遮挡、形态姿势不同的行人目标,YOLOv5模型对于这些目标检测有明显的漏检问题,提出一种像素差异度注意力机制(pixel difference attention,PDA),不同于传统的通道注意力机制用全局均值池化(global average pooling,GAP)、全局最大值池化(global max pooling,GMP)来概括整张特征图的信息,全局池化将空间压缩成一个值来表征整个通道,造成了空间信息的流失,PDA将空间信息沿高和宽分别压缩,并将其分别与通道信息联系起来做注意力加权操作,同时提出一种新的通道描述指标表征通道信息,增强空间信息与通道信息的交互,使模型更容易关注到综合了空间和通道维度上的特征图的重要信息,在主干网络末端插入PDA后使模型平均精度(mean average precision,mAP)0.5提升了2.4个百分点,mAP0.5:0.95提升了4.4个百分点;针对实时检测场景的部署和检测速度要求模型拥有较少的参数量和计算量,因此提出了新的轻量化特征提取模块AC3代替原YOLOv5模型中的C3模块,该模块使插入PDA后的改进模型在精度仅仅损失0.2个百分点的情况下,参数量(parameters,Param.)减少了20%左右,浮点运算量(giga floating-point operations,GFLOPs)减少了30%左右。实验结果表明,最终的改进模型比YOLOv5s原模型在VOC行人数据集上mAP0.5提升了2.2个百分点,mAP0.5:0.95提升了3.1个百分点,且参数量减少了20%左右,浮点运算量减少了30%左右,在GTX1050上的检测速度(frames per second,FPS)提升了4。
